EBV Ties MS Pave Treatments, New Pill Slashes LDL for Statin Patients, AI Stethoscope Detects Heart Disease, Asundexian Slashes Recurrent Strokes, and more...

(0:10): UCSF Study Links Epstein-Barr Virus to Multiple Sclerosis, Paving Way for New Treatments(2:11): New Pill Enlicitide Promises Significant LDL Reduction for High-Risk Patients on Statins(4:24): AI Stethoscope Boosts Heart Disease Detection, Offering 92% Sensitivity Over Traditional Methods(4:59): Asundexian Promising in Stroke Trial: Cuts Recurrent Stroke Without Raising Bleeding Risk(6:47): Meha Jain Wins Inaugural ASU-Science Prize for Pioneering Satellite Research in Climate-Resilient FarmingTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Medical Xpress